Evidence map›Paper›PMID 30363960›Full record

ArticleCase reports in surgery2018

Gigantic GIST: A Case of the Largest Gastrointestinal Stromal Tumor Found to Date.

Abdalla Mohamed, Youssef Botros, Paul Hanna, Sang Lee, Walid Baddoura, Jamshed Zuberi, Tanuja Damani

Abstract readCase Reports
In one paragraph

Article in Case reports in surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdalla MohamedDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0000-0002-5803-6693
Youssef BotrosDivision of Gastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Paul HannaDepartment of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0000-0001-5946-7308
Sang LeeDepartment of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA.
Walid BaddouraDivision of Gastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Jamshed ZuberiDepartment of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA.
Tanuja DamaniDepartment of Surgery, St. Joseph's University Medical Center, Paterson, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumors are uncommon when compared to all gastrointestinal neoplasms but are the most common mesenchymal tumors of the gastrointestinal tract. The largest gastrointestinal stromal tumor ever recorded in literature weighed approximately 6.1 kg and measured 39 cm × 27 cm × 14 cm. About two-thirds of GISTs are malignant. The tumor size, mitotic rate, cellularity, and nuclear pleomorphism are the most important parameters when considering prognosis and recurrence. The definitive treatment for these tumors is resection. In the year 2000, the first patient was treated with the tyrosine kinase inhibitor imatinib and since then, gastrointestinal stromal tumors with high-risk features have been treated successfully with tyrosine kinase inhibitors. We present the largest gastrointestinal stromal tumor recorded in medical literature measuring 42.0 cm × 31.0 cm × 23.0 cm in maximum dimensions and weighing in at approximately 18.5 kg in a 65-year-old African-American male who presented with increased abdominal distention. The mass was successfully excised, and the patient was treated with imatinib without local or distant recurrence 1.5 years postoperatively.

Identifiers

PMID30363960
PMCPMC6186361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.